Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1535-73-5 | MDL No. : | MFCD00041511 |
Formula : | C7H6F3NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | SADHVOSOZBAAGL-UHFFFAOYSA-N |
M.W : | 177.12 | Pubchem ID : | 73753 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 37.53 |
TPSA : | 35.25 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.86 cm/s |
Log Po/w (iLOGP) : | 1.65 |
Log Po/w (XLOGP3) : | 2.14 |
Log Po/w (WLOGP) : | 3.44 |
Log Po/w (MLOGP) : | 1.64 |
Log Po/w (SILICOS-IT) : | 1.67 |
Consensus Log Po/w : | 2.11 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.52 |
Solubility : | 0.53 mg/ml ; 0.00299 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.51 |
Solubility : | 0.545 mg/ml ; 0.00308 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.66 |
Solubility : | 0.385 mg/ml ; 0.00217 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.47 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H312-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
14% | Stage #1: With sulfuric acid; sodium nitrite In water at -5℃; for 0.25 h; Stage #2: With potassium iodide In water at 20℃; |
l-Iodo-3-(trifluoromethoxy)benzene:; To 3-(trifluoromethoxy)beπzenamine (17.7 g, 100.00 mmol) was added a solution OfNaNO2 (7.4 g, 115.62 mmol) in H2O (80 ml). H2SO4 (25 g, 250.00 mmol) was added dropwise with stirring at -5 °C. The resulting solution was kept at -5 °C for 15 minutes. To this solution was added a solution of KI (20 g, 120,48 mmol) in H2O (60 ml) dropwise, The resulting solution was stirred overnight at room temperature and extracted with EtOAc (2 X 100 mL). The combined organic layers were washed with Na2SO3/H2O (2 X 50 mL), dried over Na2SO4 and concentrated in vacuo. The residue was purified by silica gel column chromatography to afford 4.0 g (14percent) of l-iodo-3- (trifluoromethoxy)benzene. |
[ 658-89-9 ]
4-(Trifluoromethoxy)benzene-1,2-diamine
Similarity: 0.94
[ 658-89-9 ]
4-(Trifluoromethoxy)benzene-1,2-diamine
Similarity: 0.94
[ 658-89-9 ]
4-(Trifluoromethoxy)benzene-1,2-diamine
Similarity: 0.94
[ 658-89-9 ]
4-(Trifluoromethoxy)benzene-1,2-diamine
Similarity: 0.94
[ 658-89-9 ]
4-(Trifluoromethoxy)benzene-1,2-diamine
Similarity: 0.94
[ 133115-55-6 ]
(3-(Trifluoromethoxy)phenyl)hydrazine hydrochloride
Similarity: 0.87
[ 133115-72-7 ]
(4-(Trifluoromethoxy)phenyl)hydrazine hydrochloride
Similarity: 0.85